Mirvetuximab Soravtansine
OncoPharm
00:00
Mechanism: Folate Receptor Alpha–Targeted ADC
John asks how mervituximab‑seravtansine works and explains it binds folate receptor alpha, is internalized, and releases a DM4 microtubule inhibitor.
Play episode from 00:42
Transcript
